XML 23 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill And Intangible Assets
3 Months Ended
Jan. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets
Goodwill and Intangible Assets
The following table summarizes goodwill activity by reportable segment during the three months ended January 30, 2016 (in thousands):
 
Storage Area Networking (“SAN”) 
Products
 
Internet Protocol (“IP”) Networking Products
 
Global Services
 
Total
Balance at October 31, 2015
 
 
 
 
 
 
 
Goodwill
$
176,325

 
$
1,414,634

 
$
155,416

 
$
1,746,375

Accumulated impairment losses

 
(129,214
)
 

 
(129,214
)
 
176,325

 
1,285,420

 
155,416

 
1,617,161

Tax adjustments (1)
(4
)
 

 

 
(4
)
Translation adjustments

 
(116
)
 

 
(116
)
Balance at January 30, 2016
 
 
 
 
 
 
 
Goodwill
176,321

 
1,414,518

 
155,416

 
1,746,255

Accumulated impairment losses

 
(129,214
)
 

 
(129,214
)
 
$
176,321

 
$
1,285,304

 
$
155,416

 
$
1,617,041


(1) 
The goodwill adjustments were primarily a result of tax benefits from the exercise of stock awards of acquired companies.
The Company conducts its goodwill impairment test annually, as of the first day of the second fiscal quarter, and whenever events occur or facts and circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. For the annual goodwill impairment test, the Company uses the income approach, the market approach, or a combination thereof to determine each reporting unit’s fair value. The income approach provides an estimate of fair value based on discounted expected future cash flows (“DCF”). The market approach provides an estimate of fair value by applying various observable market-based multiples to the reporting unit’s operating results and then applying an appropriate control premium. For the fiscal year 2015 annual goodwill impairment test, the Company used a combination of approaches to estimate each reporting unit’s fair value. At the time that the fiscal year 2015 annual goodwill impairment test was performed, the Company believed that the income approach and the market approach were equally representative of a reporting unit’s fair value.
Determining the fair value of a reporting unit requires judgment and involves the use of significant estimates and assumptions. The Company based its fair value estimates on assumptions it believes to be reasonable but are inherently uncertain. Estimates and assumptions with respect to the determination of the fair value of its reporting units using the income approach include, among other inputs:
The Company’s operating forecasts;
The Company’s forecasted revenue growth rates; and
Risk-commensurate discount rates and costs of capital.
The Company’s estimates of revenues and costs are based on historical data, various internal estimates, and a variety of external sources, and are developed as part of the Company’s regular long-range planning process. The control premium used in market or combined approaches is determined by considering control premiums offered as part of the acquisitions that have occurred in market segments that are comparable with the Company’s reporting units.
Based on the results of the annual goodwill impairment analysis performed during the second fiscal quarter of 2015, the Company determined that no impairment needed to be recorded. As of January 30, 2016, no new events had occurred nor had any facts or circumstances changed since the annual goodwill impairment analysis performed during the second quarter of fiscal year 2015 that indicated that the fair values of the reporting units may be less than their current carrying amounts.
Intangible assets other than goodwill are amortized on a straight-line basis over the following estimated remaining useful lives, unless the Company has determined these lives to be indefinite. The Company did not incur costs to renew or extend the term of any acquired finite-lived intangible assets during the three months ended January 30, 2016.
The following tables present details of the Company’s intangible assets, excluding goodwill (in thousands, except for weighted-average remaining useful life):
 
January 30, 2016
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Net
Carrying
Value
 
Weighted-
Average
Remaining
Useful Life
(in years)
Finite-lived intangible assets:
 
 
 
 
 
 
 
Trade names
$
1,090

 
$
471

 
$
619

 
4.23
Core/developed technology (1) (2)
51,750

 
11,719

 
40,031

 
3.70
Patent portfolio license (3)
7,750

 
1,125

 
6,625

 
17.49
Customer relationships
23,110

 
3,233

 
19,877

 
6.94
Non-compete agreements
1,050

 
744

 
306

 
0.93
Patents with broader applications
1,040

 
58

 
982

 
14.13
Total finite-lived intangible assets
85,790

 
17,350

 
68,440

 
6.12
Indefinite-lived intangible assets, excluding goodwill:
 
 
 
 
 
 
 
In-process research and development (“IPR&D”) (1)
2,850

 

 
2,850

 
 
Total indefinite-lived intangible assets, excluding goodwill
2,850

 

 
2,850

 
 
Total intangible assets, excluding goodwill
$
88,640

 
$
17,350

 
$
71,290

 
 
 
 
 
 
 
 
 
 
 
October 31, 2015
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Net
Carrying
Value
 
Weighted-
Average
Remaining
Useful Life
(in years)
Finite-lived intangible assets:
 
 
 
 
 
 
 
Trade names
$
1,090

 
$
415

 
$
675

 
4.36
Core/developed technology (2)
40,530

 
9,605

 
30,925

 
3.49
Patent portfolio license (3)
7,750

 
849


6,901

 
17.74
Customer relationships
23,110

 
2,484

 
20,626

 
7.18
Non-compete agreements
1,050

 
664

 
386

 
1.17
Patents with broader applications
1,040

 
40

 
1,000

 
14.38
Total finite-lived intangible assets
74,570

 
14,057

 
60,513

 
6.55
Indefinite-lived intangible assets, excluding goodwill:
 
 
 
 
 
 
 
IPR&D (1)
15,110

 

 
15,110

 
 
Total indefinite-lived intangible assets, excluding goodwill
15,110

 

 
15,110

 
 
Total intangible assets, excluding goodwill
$
89,680

 
$
14,057

 
$
75,623

 
 

(1) 
Acquired IPR&D are intangible assets accounted for as indefinite-lived assets until the completion or abandonment of the associated research and development efforts. If the research and development efforts associated with the IPR&D are successfully completed, then the IPR&D intangible assets will be amortized over the estimated useful lives to be determined as of the date the efforts are completed. During the three months ended January 30, 2016, research and development efforts were completed on $12.3 million of the IPR&D intangible assets, and the completed IPR&D intangible assets are being amortized as Core/developed technology over an estimated useful life of five years. The research and development efforts associated with the remaining IPR&D intangible assets are expected to be completed in the second quarter of fiscal year 2016.
(2) 
During the three months ended January 30, 2016$1.0 million of finite-lived intangible assets became fully amortized and, therefore, were removed from the balance sheet.
(3) 
The patent portfolio license was assigned an estimated useful life that reflects the Company’s consumption of the expected defensive benefits related to this license to certain patents. The method of amortization for the patent portfolio license reflects the Company’s estimate of the pattern in which these expected defensive benefits will be used by the Company and is primarily based on the mix of expiration patterns of the individual patents included in the license.
The Company conducts the IPR&D impairment test annually, as of the first day of the second fiscal quarter, or when events occur or facts and circumstances indicate that it is more likely than not that the IPR&D is impaired. For the annual IPR&D impairment test, the Company elects the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of the IPR&D assets is less than the carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the IPR&D assets is less than the carrying amount, then the Company conducts a quantitative analysis to determine the fair value of the IPR&D assets. If the carrying amount of the IPR&D assets exceeds the fair value, then the Company recognizes an impairment loss equal to the difference.
Based on the results of the annual IPR&D impairment analysis performed during the second fiscal quarter of 2015, the Company determined that no impairment needed to be recorded. As of January 30, 2016, no new events had occurred nor had any facts or circumstances changed since the annual IPR&D impairment analysis performed during the second quarter of fiscal year 2015 that indicated that the fair value of the IPR&D assets may be less than the current carrying amount.
The amortization of finite-lived intangible assets is included in the following line items of the Company’s Condensed Consolidated Statements of Income as follows (in thousands):
 
Three Months Ended
 
January 30, 2016
 
January 31, 2015
Cost of revenues
$
3,154

 
$
637

General and administrative (1)
277



Amortization of intangible assets
902

 
138

Total
$
4,333

 
$
775


(1) 
The amortization is related to the $7.8 million of perpetual, nonexclusive license to certain patents purchased during the fiscal year ended October 31, 2015.
The following table presents the estimated future amortization of finite-lived intangible assets as of January 30, 2016 (in thousands):
Fiscal Year
 
Estimated
Future
Amortization
2016 (remaining nine months)
 
$
12,894

2017
 
16,757

2018
 
12,238

2019
 
8,709

2020
 
7,620

Thereafter
 
10,222

Total
 
$
68,440